Altered plasma levels of cytokines in patients with ischemic heart disease

被引:56
|
作者
Tashiro, H
Shimokawa, H
Yamamoto, K
Momohara, M
Tada, H
Takeshita, A
机构
[1] KYUSHU UNIV,SCH MED,RES INST ANGIOCARDIOL,HIGASHI KU,FUKUOKA 81282,JAPAN
[2] KYUSHU UNIV,SCH MED,CARDIOVASC CLIN,HIGASHI KU,FUKUOKA 81282,JAPAN
关键词
cytokine; ischemic heart disease; unstable angina; macrophage colony-stimulating factor; transforming growth factor-beta;
D O I
10.1097/00019501-199703000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cytokines play an important role in mediating inflammatory-proliCerative responses, including atherosclerosis, Alterations in the plasma levels of cytokines in patients with ischemic heart disease (IHD) remain to be examined, Objective To examine the possible alterations in the plasma levels of cytokines in patients with IHD and in controls, Methods Thirty-one patients with IHD and 16 controls were studied, The cytokines measured in our study included interleukin-6, macrophage-colony-stimulating factor (MCSF), transforming growth factor-beta (TGF-beta), and seven other major cytokines, The measurements were performed by using an enzyme-linked immunosorbent assay method, Results The MCSF levels were significantly higher in patients with IHD than they were in controls (P< 0.01), whereas the TGF-beta levels were significantly lower in patients with IHD than they were in controls (P< 0.01). Moreover, the levels of MCSF and those of TGF-beta were correlated negatively (P< 0.05), The interleukin-6 levels tended to be higher in patients with unstable angina, The plasma levels of other cytokines were below the detection levels in most cases, Conclusions Results from studies in vitro suggested that the process of atherosclerosis is accelerated and inhibited by MCSF and TGF-beta, respectively, The present results thus suggest that the alterations in the plasma levels of MCSF and TGF-beta may be involved in the pathogenesis of IHD in humans,
引用
收藏
页码:143 / 147
页数:5
相关论文
共 50 条
  • [41] High Serum Levels of Rheumatoid Factor and Anti-Phosphatidylserine Antibody in Patients with Ischemic Heart Disease
    Jafarzadeh, Abdollah
    Poorgholami, Masoud
    Nemati, Maryam
    Rezayati, Mohammad-Taghi
    IRANIAN JOURNAL OF IMMUNOLOGY, 2011, 8 (01) : 34 - 44
  • [42] Predictors of incident heart failure in a cohort of patients with ischemic heart disease
    Abdissa, Senbeta Guteta
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [43] Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease
    Razani, Zahra
    Dastani, Mostafa
    Kazerani, Hamid Reza
    PHYTOTHERAPY RESEARCH, 2017, 31 (11) : 1731 - 1738
  • [44] Psychosomatic interrelations in patients with ischemic heart disease and alexithymia
    Provotorov, VM
    Budnevsky, AV
    Kravtchenko, AY
    Grekova, TI
    KARDIOLOGIYA, 2001, 41 (02) : 46 - 49
  • [45] Management of Patients with Ischemic Heart Disease in Spine Surgery
    Song, Myung-Geun
    Kim, Chang-Won
    Song, Sang-Youn
    Kim, Han-Gyul
    Kim, Dong-Hee
    ASIAN SPINE JOURNAL, 2023,
  • [46] Global circumferential strain in patients with ischemic heart disease
    Roman-Fernandez, Idalys
    Perez-Barreda, Aylen
    Naranjo-Dominguez, Adrian
    Rodriguez-Navarro, Angel Y.
    Alfonso-Montero, Oscar A.
    CORSALUD, 2021, 13 (01): : 9 - 18
  • [47] Treatment of ischemic heart disease in patients with gastrointestinal diseases
    Komissarenko, IA
    TERAPEVTICHESKII ARKHIV, 2006, 78 (02) : 72 - 76
  • [48] Pirazidol treatment of depressions in patients with ischemic heart disease
    Ivanov, SV
    Syrkin, AL
    Drobizhev, MY
    Poltavskaya, MG
    Baturin, KA
    Burlakov, AV
    TERAPEVTICHESKII ARKHIV, 2003, 75 (10) : 38 - 42
  • [49] The role of clopidogrel in the management of patients with ischemic heart disease
    Chopra, V
    Marmur, JD
    Cavusoglu, E
    CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (5-6) : 467 - 477
  • [50] Assessment of Plateletcrit as Biomarker in Ischemic Heart Disease Patients
    Abass, Awad-Elkareem
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2025, 15 (01) : 222 - 225